Exendin agonist formulations and methods of administration thereof
US6902744B1 · kind B1 · utility
126Cited by
3References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2000 |
| Grant date | Jun 7, 2005 |
| Priority date | — |
| Expiry date | Jan 14, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.